|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
1497246 |
| 003 |
ICU |
| 005 |
19970810131200.0 |
| 008 |
930913s1993 nyua b 001 0 eng c |
| 010 |
|
|
|a 93008117
|
| 020 |
|
|
|a 0824788931
|
| 035 |
|
|
|a (ICU)BID17440298
|
| 035 |
|
|
|a (OCoLC)28116402
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d ICU$dOrLoB
|
| 050 |
0 |
0 |
|a RM301.27
|b .D79 1993
|
| 060 |
|
0 |
|a QV 771 D7948 1993
|
| 082 |
|
|
|a 615/.1901
|2 20
|
| 245 |
0 |
0 |
|a Drug safety assessment in clinical trials /
|c edited by Gene Sogliero-Gilbert.
|
| 260 |
|
|
|a New York :
|b Dekker,
|c c1993.
|
| 263 |
|
|
|a 9307
|
| 300 |
|
|
|a x, 437 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Statistics, textbooks and monographs
|v v. 138
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Preclinical Drug Safety Evaluation /
|r James T. Mayne --
|g 2.
|t Adverse Drug Events in Clinical Trials /
|r Deborah S. Kirby --
|g 3.
|t Laboratory Testing in Clinical Trials /
|r Deborah S. Kirby --
|g 4.
|t Drug Research in the Elderly /
|r Piet M. Hooymans and Robert Janknegt --
|g 5.
|t Drug Assessment in Critical Illness /
|r M. I. Bowden and J. F. Bion --
|g 6.
|t Laboratory Data in Multicenter Trials: Monitoring, Adjustment, and Summarization /
|r Lawrence K. Oliver and Christy Chuang-Stein --
|g 7.
|t The Genie Score: A Multivariate Assessment of Laboratory Abnormalities /
|r Gene Sogliero-Gilbert, Lonni Zubkoff-Schulz and Naitee Ting --
|g 8.
|t Laboratory Parameters and Drug Safety /
|r Norman E. Pitts --
|g 9.
|t A Unified Approach to the Analysis of Safety Data in Clinical Trials /
|r Christy Chuang-Stein and Noel R. Mohberg --
|g 10.
|t The Use of Hazard Functions in Safety Analysis /
|r David S. Salsburg --
|g 11.
|t Meta-Analysis of Drug Safety Data /
|r Gary G. Koch, Judith E. Schmid, Janet M. Begun and William C. Maier --
|g 12.
|t Design and Analysis Considerations for Safety Data, Particularly Adverse Events /
|r Karl E. Peace --
|g 13.
|t Clinical Trial Adverse Drug Experience Reporting Requirements in the Major Countries: One Manufacturer's Approach /
|r Max W. Talbott and Ellen D. Kelso --
|g 14.
|t Safety Surveillance /
|r Norman E. Pitts --
|g 15.
|t Postmarketing Surveillance: Applications and Limitations, with Special Reference to the Fluoroquinolones /
|r Robert Janknegt and Yechiel A. Hekster.
|
| 650 |
|
0 |
|a Drugs
|x Testing
|0 http://id.loc.gov/authorities/subjects/sh85039755
|
| 650 |
|
0 |
|a Drugs
|x Testing
|x Statistical methods.
|
| 650 |
|
0 |
|a Drugs
|x Toxicology
|0 http://id.loc.gov/authorities/subjects/sh85039757
|
| 650 |
|
2 |
|a Drug Evaluation
|x methods
|
| 650 |
|
2 |
|a Clinical Trials
|x methods
|
| 650 |
|
7 |
|a Drugs
|x Testing.
|2 fast
|0 http://id.worldcat.org/fast/fst00898940
|
| 650 |
|
7 |
|a Drugs
|x Testing
|x Statistical methods.
|2 fast
|0 http://id.worldcat.org/fast/fst00898954
|
| 650 |
|
7 |
|a Drugs
|x Toxicology.
|2 fast
|0 http://id.worldcat.org/fast/fst00898958
|
| 700 |
2 |
0 |
|a Sogliero-Gilbert, Gene,
|d 1925-
|0 http://id.loc.gov/authorities/names/n93801704
|1 http://viaf.org/viaf/68151125
|
| 850 |
|
|
|a ICU
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 95e556a8-a35e-58fa-a6a1-57f5403a103c
|s d9e2813d-c51e-5107-8a8b-f5b704668e9b
|
| 928 |
|
|
|t Library of Congress classification
|a RM301.27.D790 1993
|l JCL
|c JCL-Sci
|i 5884845
|
| 927 |
|
|
|t Library of Congress classification
|a RM301.27.D790 1993
|l JCL
|c JCL-Sci
|e CRERAR
|b 39277497
|i 2888789
|
